Collins W E, Pye D, Crewther P E, Vandenberg K L, Galland G G, Sulzer A J, Kemp D J, Edwards S J, Coppel R L, Sullivan J S
Division of Parasitic Diseases, Centers for Disease Prevention & Control, Atlanta, Georgia.
Am J Trop Med Hyg. 1994 Dec;51(6):711-9. doi: 10.4269/ajtmh.1994.51.711.
Saimiri sciureus boliviensis monkeys were immunized with the Plasmodium fragile form of the merozoite apical membrane antigen-1 produced using the baculovirus expression system and combined with Montanide ISA 720 adjuvant. Following three immunizations, monkeys were challenged with 10,000 P. fragile trophozoite parasites. Antibody titers determined by fluorescence microscopy indicated an enhanced response following the second immunization. Four of five control animals had parasite counts > 5% 18-26 days following challenge. Four of five immunized monkeys had reduced levels of maximum parasitemia or delays in accumulated parasite counts, suggestive of protection. Rechallenge of the animals with P. falciparum resulted in three of four adjuvant control animals developing patent parasitemia whereas none of five immunized animals were infected, suggesting some level of heterologous protection.
将玻利维亚松鼠猴用杆状病毒表达系统制备的恶性疟原虫裂殖子顶端膜抗原-1的易碎形式进行免疫,并与Montanide ISA 720佐剂联合使用。三次免疫后,用10,000个恶性疟原虫滋养体寄生虫对猴子进行攻击。通过荧光显微镜测定的抗体滴度表明,第二次免疫后反应增强。五只对照动物中有四只在攻击后18-26天的寄生虫计数>5%。五只免疫猴子中有四只的最大寄生虫血症水平降低或累积寄生虫计数延迟,提示有保护作用。用恶性疟原虫对动物进行再次攻击,结果在四只佐剂对照动物中有三只出现明显的寄生虫血症,而五只免疫动物中没有一只被感染,提示有一定程度的异源保护作用。